HOME >> BIOLOGY >> NEWS
Dinosaurs in bullet-proof vests

Their armour was perfect; even their eyelids consisted of plates of bone. What are known as ankylosauruses are among the best armoured animals known to us. These herbivores were up to ten metres long, with a tail ending in a huge bony club 'probably used as a weapon', says Torsten Scheyer, 'even though they definitely could not simply swing it back and forth; the whole construction was simply too stiff for that.'

Torsten Scheyer has examined the dinosaurs' armour as part of his diploma thesis. The results are astonishing: 'The armour plating is not nearly as similar to those of the crocodile as was previously assumed,' he adds. 'Their microstructure is substantially more complex, at least in some types of ankylosaurus.'

A complete set of dinosaur chain mail was composed of hundreds of thousands of bony armour plates known as osteoderms. Most of these were smaller than a European one-cent coin, but some also had a diameter of several dozen centimetres and ended in long points. 'Unlike tortoise shells, the individual plates lay next to each other. They were not fused together,' the PhD student Torsten Scheyer explains. This kind of armour was flexible and could thus not break so easily under pressure. Although modern crocodiles have a similar kind of armour, the individual plates have a much simpler structure.

By using a polarisation microscope Torsten Scheyer discovered that collagen fibres were interwoven in the bone calcium of the dinosaur's armour plating, forming mats which were interspersed with each other three-dimensionally. Within each mat the fibres were aligned parallel to one another, with the fibres at right angles to the layer above and below them. 'The armour was thereby endowed with great strength in all directions,' Torsten Scheyer stresses. Today's composite materials are based on the same principle, which are used to make the rotor blades for wind farms or bullet-proof vests except that in these cases the collagen mats are
'"/>

Contact: Torsten Scheyer
tscheyer@uni-bonn.de
49-228-734-683
University of Bonn
16-Nov-2004


Page: 1 2

Related biology news :

1. Dinosaurs -- stones did not help with digestion
2. Dinosaurs climate shifted too, reports show
3. Arctic mystery no longer: Dinosaurs walked Canadas great north
4. Canadas new government invests $200M in the fight against the mountain pine beetle
5. Steroid discoveries could add bulk to crop harvests

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Dinosaurs bullet proof vests

(Date:5/21/2013)... When infections occur in the body, stem cells ... multiplying and differentiating into mature immune cells that ... inflammation can deplete these cell populations, potentially leading ... as cancer. Now, a team of researchers led ... (Caltech) has found that, in mouse models, the ...
(Date:5/21/2013)... phosphatidylserine is a natural food supplement produced from ... and slow memory loss, it,s a popular treatment ... team headed by Prof. Gil Ast and Dr. ... Human Molecular Genetics have discovered that ... involved in degenerative brain disorders, including Parkinson,s disease ...
(Date:5/21/2013)... , Where? Copenhagen, Denmark: Bella Center Congress ... , Why? An annual meeting ... developments, manufacturing and installation, drawing on leading experiences from ... edition from a record of more than 900 abstracts ... plenary and oral presentations, more than 460 visual presentation, ...
Breaking Biology News(10 mins):Keeping stem cells strong 2Common food supplement fights degenerative brain disorders 221st European Biomass Conference and Exhibition 221st European Biomass Conference and Exhibition 321st European Biomass Conference and Exhibition 4
(Date:5/21/2013)... 2013 Custom Learning Designs, Inc.(CLD) ... solution using Tin Can API combined with its ... is a leading developer of training content and ... worldwide. , Tin Can API is a ... and trainers more accurately measure the Return on ...
(Date:5/21/2013)... ISTANBUL , May 21, 2013 ...  European Dialysis and Transplant Association) is the biggest congress ... renal replacement therapy. Nearly 10,000 participants are in ... discuss the latest research findings. New pioneering studies have ... al. "SOLUBLE FERRIC PYROPHOSPHATE (SFP) ADMINISTERED VIA HEMODIALYSATE REDUCES ...
(Date:5/21/2013)... New York , May 21, 2013 ... by Transparency Market Research ( http://www.transparencymarketresearch.com ) "Biochip Products ... Research, IVD Tests) - U.S. Industry Analysis, Size, Share, Growth, ... 2.4 billion in 2011 and is expected to grow ... to reach an estimated value of USD 4.7 billion ...
(Date:5/21/2013)... ROCKVILLE, Md. , May 21, 2013 /PRNewswire/ ... "Phase 1 study of margetuximab (MGAH22), an Fc-modified ... solid tumors expressing the HER2 oncoprotein," will be ... American Society of Clinical Oncology during the Developmental ... June 3 at 4:15 – 4:30 PM.  The ...
Breaking Biology Technology:CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 2CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 3ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 2ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 4The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 5MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3
Cached News: